Kwang Rok Kim

1.3k total citations
29 papers, 1.1k citations indexed

About

Kwang Rok Kim is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Kwang Rok Kim has authored 29 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Kwang Rok Kim's work include Diabetes Treatment and Management (10 papers), Peptidase Inhibition and Analysis (8 papers) and Neuropeptides and Animal Physiology (7 papers). Kwang Rok Kim is often cited by papers focused on Diabetes Treatment and Management (10 papers), Peptidase Inhibition and Analysis (8 papers) and Neuropeptides and Animal Physiology (7 papers). Kwang Rok Kim collaborates with scholars based in South Korea, India and United States. Kwang Rok Kim's co-authors include Hyae Gyeong Cheon, Jin Hee Ahn, Seung Kyu Kang, Sung Soo Kim, Kyu‐Won Kim, Chul‐Ho Jeong, Sang Dal Rhee, Sun Ho Jung, Hyun Jeong Kwak and Ju‐Young Kim and has published in prestigious journals such as Journal of Biological Chemistry, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Kwang Rok Kim

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kwang Rok Kim South Korea 17 462 360 157 156 141 29 1.1k
Heather N. Tinsley United States 18 775 1.7× 383 1.1× 168 1.1× 113 0.7× 91 0.6× 36 1.3k
Marco Miceli Italy 24 836 1.8× 277 0.8× 145 0.9× 76 0.5× 65 0.5× 54 1.5k
John K. Dickson United States 17 499 1.1× 351 1.0× 114 0.7× 95 0.6× 76 0.5× 34 1.1k
Shiho Arima Japan 22 443 1.0× 447 1.2× 164 1.0× 66 0.4× 195 1.4× 122 1.3k
Hao Jia China 18 377 0.8× 418 1.2× 102 0.6× 89 0.6× 101 0.7× 59 1.3k
Akiko Ishida Japan 22 501 1.1× 154 0.4× 152 1.0× 83 0.5× 70 0.5× 58 1.1k
Thomas Harrity United States 17 611 1.3× 257 0.7× 177 1.1× 107 0.7× 60 0.4× 23 1.1k
Takashi Ono Japan 18 431 0.9× 136 0.4× 119 0.8× 88 0.6× 61 0.4× 38 1.0k
Curtis M. Tyree United States 14 513 1.1× 177 0.5× 168 1.1× 75 0.5× 65 0.5× 17 1.2k
David J. Cowan United States 10 637 1.4× 128 0.4× 95 0.6× 80 0.5× 67 0.5× 12 831

Countries citing papers authored by Kwang Rok Kim

Since Specialization
Citations

This map shows the geographic impact of Kwang Rok Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kwang Rok Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kwang Rok Kim more than expected).

Fields of papers citing papers by Kwang Rok Kim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kwang Rok Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kwang Rok Kim. The network helps show where Kwang Rok Kim may publish in the future.

Co-authorship network of co-authors of Kwang Rok Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Kwang Rok Kim. A scholar is included among the top collaborators of Kwang Rok Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kwang Rok Kim. Kwang Rok Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Ji Hye, et al.. (2018). Fluvastatin activates sirtuin 6 to regulate sterol regulatory element-binding proteins and AMP-activated protein kinase in HepG2 cells. Biochemical and Biophysical Research Communications. 503(3). 1415–1421. 26 indexed citations
2.
Kim, Ji Hye, et al.. (2018). Identification of a novel SIRT7 inhibitor as anticancer drug candidate. Biochemical and Biophysical Research Communications. 508(2). 451–457. 44 indexed citations
3.
Chae, Sieun, Dahee Kim, Kyungjin Lee, et al.. (2018). Encapsulation and Enhanced Delivery of Topoisomerase I Inhibitors in Functionalized Carbon Nanotubes. ACS Omega. 3(6). 5938–5945. 13 indexed citations
4.
Hwang, Do Won, Hyun Woo Kwon, Jaeho Jang, et al.. (2017). Neuron-Specific Fluorescence Reporter-Based Live Cell Tracing for Transdifferentiation of Mesenchymal Stem Cells into Neurons by Chemical Compound. Stem Cells International. 2017. 1–10. 7 indexed citations
5.
Jung, Kwan‐Young, Seung Kyu Kang, Haushabhau S. Pagire, et al.. (2017). Design, synthesis, and biological evaluation of aryl N-methoxyamide derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 27(16). 3909–3914. 11 indexed citations
6.
Kim, Hyojin, Seung Kyu Kang, Kwang Rok Kim, et al.. (2017). Synthesis and biological evaluation of thiazole derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 27(23). 5213–5220. 20 indexed citations
7.
Park, Sung Bum, Hyo‐Jin Jeon, Won Hoon Jung, et al.. (2015). Optimization of Enzyme Activity Assay for Screening of Acryl CoA: Monoacylglycerol Acyltransferase 2 Inhibitors. Bulletin of the Korean Chemical Society. 36(5). 1433–1438. 1 indexed citations
8.
Kang, Seung Kyu, Kwan‐Young Jung, Ashok Kumar Jaladi, et al.. (2014). Synthesis and biological evaluation of thienopyrimidine derivatives as GPR119 agonists. Bioorganic & Medicinal Chemistry Letters. 24(17). 4281–4285. 10 indexed citations
9.
Kwak, Hyun Jung, Ji Young Kim, Haushabhau S. Pagire, et al.. (2013). Synthesis and biological evaluation of aminobenzimidazole derivatives with a phenylcyclohexyl acetic acid group as anti-obesity and anti-diabetic agents. Bioorganic & Medicinal Chemistry Letters. 23(16). 4713–4718. 41 indexed citations
10.
Kang, Seung Kyu, Ki Young Kim, Sang Dal Rhee, et al.. (2011). Discovery of β-aminoacyl containing thiazolidine derivatives as potent and selective dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(5). 1366–1370. 12 indexed citations
11.
Kim, Kwang Rok, et al.. (2010). Discovery of cannabinoid-1 receptor antagonists by virtual screening. Bioorganic & Medicinal Chemistry Letters. 20(17). 5130–5132. 6 indexed citations
12.
Ahn, Jin Hee, Seung Kyu Kang, Ki Young Kim, et al.. (2008). Synthesis and biological evaluation of homopiperazine derivatives with β-aminoacyl group as dipeptidyl peptidase IV inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(24). 6525–6529. 19 indexed citations
13.
Kang, Seung Kyu, Ki Young Kim, Kwang Rok Kim, et al.. (2008). Synthesis and biological evaluation of pyrazoline analogues with β-amino acyl group as dipeptidyl peptidase IV inhibitors. European Journal of Medicinal Chemistry. 43(9). 1889–1902. 25 indexed citations
14.
Ahn, Jin Hee, Sun Ho Jung, Seung Kyu Kang, et al.. (2007). Synthesis, biological evaluation and structural determination of β-aminoacyl-containing cyclic hydrazine derivatives as dipeptidyl peptidase IV (DPP-IV) inhibitors. Bioorganic & Medicinal Chemistry Letters. 17(9). 2622–2628. 41 indexed citations
15.
Bhattarai, Bharat Raj, Seung Wook Ham, Kwang Rok Kim, et al.. (2007). 2-O-Carboxymethylpyrogallol derivatives as PTP1B inhibitors with antihyperglycemic activity. Bioorganic & Medicinal Chemistry Letters. 17(19). 5357–5360. 15 indexed citations
16.
Ahn, Jin Hee, Sun Ho Jung, Jin Ah Kim, et al.. (2007). Synthesis and structure–activity relationship of novel indene N-oxide derivatives as potent peroxisome proliferator activated receptor γ (PPARγ) agonists. Bioorganic & Medicinal Chemistry Letters. 17(18). 5239–5244. 21 indexed citations
17.
Jeong, Chul‐Ho, HJ Lee, Jong‐Ho Cha, et al.. (2007). Hypoxia-inducible Factor-1α Inhibits Self-renewal of Mouse Embryonic Stem Cells in Vitro via Negative Regulation of the Leukemia Inhibitory Factor-STAT3 Pathway. Journal of Biological Chemistry. 282(18). 13672–13679. 81 indexed citations
18.
Kim, Kwang Rok, Jeong Hyun Lee, Seung Jun Kim, et al.. (2006). KR-62980: A novel peroxisome proliferator-activated receptor γ agonist with weak adipogenic effects. Biochemical Pharmacology. 72(4). 446–454. 51 indexed citations
19.
Ahn, Jin Hee, Jin Ah Kim, Hye-Min Kim, et al.. (2005). Synthesis and evaluation of pyrazolidine derivatives as dipeptidyl peptidase IV (DP-IV) inhibitors. Bioorganic & Medicinal Chemistry Letters. 15(5). 1337–1340. 33 indexed citations
20.
Ahn, Jin Hee, Hye-Min Kim, Sun Ho Jung, et al.. (2004). Synthesis and DP-IV inhibition of cyano-pyrazoline derivatives as potent anti-diabetic agents. Bioorganic & Medicinal Chemistry Letters. 14(17). 4461–4465. 106 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather N. Tinsley Breakdown of academic impact, for papers by Marco Miceli Breakdown of academic impact, for papers by John K. Dickson Breakdown of academic impact, for papers by Shiho Arima Breakdown of academic impact, for papers by Hao Jia Breakdown of academic impact, for papers by Akiko Ishida Breakdown of academic impact, for papers by Thomas Harrity Breakdown of academic impact, for papers by Takashi Ono Breakdown of academic impact, for papers by Curtis M. Tyree Breakdown of academic impact, for papers by David J. Cowan
Rankless by CCL
2026